Type 1 ring chaperones - 7 membered rings of identical 60 kDa subunits
Type 2 ring chaperones:
8 membered rings
60 kDa subunits
Action of type 1 ring chaperones:
Ring of the hydrophobic residues lining upper part of cavities binds non native polypeptides from hsp70
ATP binding in the cis ring / double ring
ATP binding in trans releases GroES and polypeptide
ATP binding in the double ring causes the movement of hydrophobic residues of chaperonin away from polypeptide which is released into cavity
Binding of GroEScap results in expansion of cavity to form folding cage with hydrophilic lining
GroEL (bacteria) and TRiC (eukaryote) accept some newly synthesised polypeptides from DNAK (bacteria) or Hsp70 (eukaryote) - Hsp60 accepts polypeptides newly imported into mitochondrion from Hsp70
Mechanism of ring chaperones:
Substrate binding to GroEL (may result in local unfolding)
ATP binding triggers conformational rearrangement of the GroEL apical domain
Binding of GroES and substrate encapsulation for folding
ADP and GroES dissociate from the opposite transGroELring - releases the substrate
New substrate remains encapsulated for the time needed to hydrolyse sevenATP molecules in the cis complex
ATP and GroES bind to the trans ring causing the opening of the cis complex
mechanism of release of polypeptide into the folding cavity:
When ATP binds, apical (A) and equatorial (E) domains rotate around intermediate (I) hinge domain
hydrophobic residues repel from the cavity allowing GroES to bind
Causes further rotation of hydrophobic domains away from the cavity lining - releasing polypeptide to fold in cavity
Ring chaperones in prokaryotes:
Small polypeptides (25 kDa) fold without GroEL
Large polypeptides require GroEL
Size limit of 55 kDa for polypeptides in GroEL cavity
About 10 - 15 % of newly synthesised polypeptides associate with GroEL
Ring chaperones in eukaryotes:
Polypeptides tend to fold in domains co-translationally - assisted by hsc70
Non contigous sequences of domains are released to TRiC for posttranslationalfolding
Larger multi domain polypeptides don't fit into TRiC
Hsp90 substrates include signalling molecules e.g. kinases, steroid receptors etc
Hsp90 cycle:
ATP binds to the N terminal ATPase domain of apo hsp90 - induces conformational change and closure of the ATPlid in the n terminal domain
n terminal domain dimerize forming the closed hsp90 dimer with twisted subunits
The stable confirmation is committed for ATPhydrolysis
The n terminal domain dissociates causing the substrate to interact with the middle domain
Substrate is activated
During the hsp90 cycle, the co factors CDC37, HOP, AHA1, and p23 accelerate or slow steps in the cycle
Hsp90 and steroid hormones:
Hormonereceptor and hsp90 complex formed in cytosol
Hormone binding releases hsp90 and exposes nuclear localization signal
Hormonereceptor moves into the nucleus
The activereceptor binds to the DNA, activating transcription
Hsp90 substrates are linked to cancer - hsp90 ATPase inhibitors can be used
Other non ATPase chaperones involved in folding:
Eukaryotes/archaea - GimC binds to newly synthesised polypeptides and passes them to TRiC - especially actin and tubulin
E.coli - contains TriggerFactor (TF), closely associated with the ribosome which may replicate the role of DNAK
GimC is a heterohexamer that delivers proteins to chaperonins
GimC is a 120 amino acid protein that consists of 2alpha subunits and 4beta subunits - substrates bind into the interhelixhydrophobic regions
GimC acts as a transport molecule to direct target protein and specifally binds to cytoplasmicchaperonin (CCT)
Trigger factor chaperones are highly abundant 48 kDa protein that binds to ribosomal L23 protein near the ribosomes exittunnel
Trigger factor binds nascent chains via multiple low affinity interactions with inner surface and assists folding by preventing aggregation - causes an upstream of DNAK and GroEL / GroES